AngioWaveNet vs EchoSolv AS
AI Verdict
Choose AngioWaveNet if…
Choose AngioWaveNet if your primary need is to enhance the visual clarity of fluoroscopic angiograms during or after cardiac catheterization procedures. This tool is ideal for interventional cardiologists and vascular surgeons seeking improved visualization of blood vessels and anatomical structures to aid in diagnosis, intervention planning, and procedural guidance. It integrates seamlessly into existing cath lab workflows to optimize image quality.
View AngioWaveNet →Choose EchoSolv AS if…
Choose EchoSolv AS if your focus is on accurately and efficiently identifying patients at high risk for severe aortic stenosis from echocardiogram measurements. This platform is best suited for cardiology departments needing a clinical decision support tool to prioritize studies for closer review and streamline the diagnostic process for a specific cardiac condition. It provides ultra-fast risk detection and consistent probability analysis without requiring image-based AI.
View EchoSolv AS →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AngioWaveNet | EchoSolv AS |
|---|---|---|
| Pricing | Pricing options include annual software licensing or subscription-based access, tailored to cath lab volume and hospital needs. custom packages are available. | Unknown |
| Deployment | Cloud-based or on-premise/servers | Cloud-based |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
TieBoth tools emphasize seamless integration into existing clinical workflows. AngioWaveNet is vendor-agnostic and functions as a DICOM endpoint, while EchoSolv AS integrates with PACS and boasts ultra-fast risk detection, requiring no EMR integration. Both prioritize ease of use and minimal disruption to current operations.
Clinical Value
EchoSolv ASWhile AngioWaveNet offers direct image enhancement for improved vessel visualization, EchoSolv AS provides AI-powered clinical decision support for severe aortic stenosis with high accuracy and efficiency. EchoSolv AS also offers 'second reader support' and 'consistent severe AS probability and guideline check from measurements,' which directly aids in patient identification and prioritization, demonstrating a more explicit and quantifiable clinical impact.
Pricing & Value
EchoSolv ASAngioWaveNet offers flexible pricing options including annual licensing or subscription. EchoSolv AS, however, provides more transparent value by detailing a subscription-based model with an identified reimbursement pathway (Miscellaneous Code 93799) and expected fee-per-use rates, offering a clearer financial proposition for healthcare providers.
Enterprise Readiness
AngioWaveNetBoth tools are FDA-cleared and HIPAA compliant, essential for enterprise adoption. However, AngioWaveNet offers both cloud-based and on-premise/server deployment options, providing greater flexibility for organizations with diverse infrastructure and data governance requirements. EchoSolv AS is solely cloud-based.
Innovation
TieAngioWaveNet utilizes AI-powered Spatiotemporal Enhancement Processing (STEPu2122) for advanced post-processing image enhancement, revealing vessel details not visible in unprocessed angiograms. EchoSolv AS employs a unique measurement-based AI that analyzes numerical data from echocardiograms to identify severe AS risk, rather than raw images, which is an innovative approach to clinical decision support.
Support & Docs
EchoSolv ASAngioWaveNet offers onboarding support, installation assistance, and staff training. EchoSolv AS, in addition to general support, provides a comprehensive 'Trust Center' with SOC 2 Type II and HIPAA audit reports, privacy policy, and specific documentation to aid hospitals with reimbursement processes, demonstrating a more robust and transparent support framework for enterprise clients.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AngioWaveNet | EchoSolv AS |
|---|---|---|
| Name | AngioWaveNet | EchoSolv AS |
| Company | Angiowave Imaging | Echo IQ |
| Description | FDA-cleared AI software that enhances fluoroscopic angiograms for improved vessel visualization in cardiac catheterization laboratories, integrating with existing Cath lab workflows. | FDA-cleared, AI-powered clinical decision support platform by Echo IQ that analyzes echocardiograms to identify patients at risk for severe aortic stenosis with high accuracy and efficiency, integrating into existing workflows. |
| Primary Function | Enhances fluoroscopic angiograms for improved vessel visualization | Analyzes echocardiograms to identify patients at risk for severe aortic stenosis |
| Data Input Type | Fluoroscopic angiograms (images) | Echocardiogram measurements (numerical measurements) |
| Integration | Integrates with existing Cath lab workflows; Functions as a DICOM endpoint for imaging systems | Designed to fit existing workflows (no EMR integration required, integrates with PACS) |
Videos
Demos, reviews, and walkthroughs featuring AngioWaveNet and EchoSolv AS.